Pliant Therapeutics Stock Discussion

$Pliant Therapeutics (PLRX.US)$
Breakthrough: New Cancer Drug Achieves 74% Tumor Reduction in Phase 1 Study

$Pliant Therapeutics (PLRX.US)$
Pliant Therapeutics Announces Interim Phase 1 Data for PLN-101095 in Patients with Immune Checkpoint Inhibitor-Refractory Advanced Solid Tumors
Monday, 17th March at 8:00 am
Antitumor activity observed with confirmed partial responses in 50% of patients
at highest dose tested to date, across multiple tumor types
PLN-101095 was generally well tolerated across all doses
SOUTH SAN FRANCISCO, Calif., March 17, 2025 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (NA...

$Pliant Therapeutics (PLRX.US)$
Polyrizon Launches Preclinical Studies for Intranasal Naloxone to Combat Opioid Overdose Using Cutting-Edge Platform
Thursday, 13th March at 7:51 am
Raanana, Israel, March 13, 2025 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (NASDAQ: PLRZ) (the "Company" or "Polyrizon"), a development stage biotech company specializing in the development of innovative intranasal hydrogels, previously announced the initiation of preclinical studies for intranasal Naloxone, a life-saving...

$Pliant Therapeutics (PLRX.US)$ going to 85 cents

$Pliant Therapeutics (PLRX.US)$ You guys thinking this will shoot up again or is it dying?

$Pliant Therapeutics (PLRX.US)$
Failed Safety Reviews Force Pliant to Abandon Key IPF Drug Trial - What's Next for Their Pipeline?

$Pliant Therapeutics (PLRX.US)$ 2.8 enter. 3.7 out its a homerun guys！

$Pliant Therapeutics (PLRX.US)$  Save your money and let this one die!

$Pliant Therapeutics (PLRX.US)$ can't wait for the unpause because this will shoot up